ARGX:NASDAQ
argenx SE - ADR
930,52 USD
arrow_upward
+1,93%(+17,65) 1D
931,35 USD
arrow_upward
+0,09% (+0,83)bedtimeAfter hours
Closed: 6-окт., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
922,39 USD
High
942,35 USD
Low
909,94 USD
Mkt. cap
58,45 млд
Avg. vol.
255,97 миң
Volume
12,00
P/E ratio
35,35
52-wk high
1 072,75 USD
52-wk low
661,85 USD
EPS
26,32 USD
Beta
0,45
Shares outstanding
62,56 млн
No. of employees
2 миң
Open
922,39 USD
High
942,35 USD
Low
909,94 USD
Mkt. cap
58,45 млд
Avg. vol.
255,97 миң
Volume
12,00
P/E ratio
35,35
52-wk high
1 072,75 USD
52-wk low
661,85 USD
EPS
26,32 USD
Beta
0,45
Shares outstanding
62,56 млн
No. of employees
2 миң
News stories
From web sources and news partners
AD HOC NEWS
·
3 саат мурун
Goldman Sachs raises target for Argenx stock to EUR 982.00
Investing.com UK
·
14 саат мурун
Halozyme expands argenx collaboration with two new targets By Investing.com
Stock Titan
·
14 саат мурун
A drug-delivery partnership expands from six exclusive targets to eight.
AD HOC NEWS
·
17 саат мурун
argenx stock: New VYVGART data span myasthenia gravis and CIDP
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR